New

Chrome Plugin Live! Redefine the way you read FinTwit 🚀 Install Now

You have successfully sign out
Loading...
Shape
RadNet, Inc.
RDNT
Shape
US Flag

NASDAQ

4B

Medical - Diagnostics & Research

Next Earning date - 06 Aug 2025

4B

Medical - Diagnostics & Research

Next Earning date - 06 Aug 2025

55.62USD

Shape-1.29 ( -2.27%)
Market Closed (as of Jul 01, 20:00 EDT)
favorite-chart

Relative Strenght

74
favorite-chart

Volume Buzz

-11%
favorite-chart

Earning Acce

No
favorite-chart

Dist 52w H.

41%

Quote Panel

Shape
Updated July 2, 2025
1W -4.19 % 1M -5.25 % 3M 12.34 % 1Y -6.14 %

Key Metrics

Shape
  • Market Cap

    4.17B


  • Shares Outstanding

    75.03M


  • Share in Float

    67.01M


  • Dividende

    0


  • Earning Date

    06 Aug 2025


  • Price Target

    55.62


  • Average Volume

    729978


  • Beta

    1.436


  • Range

    45.001-93.65


  • Industry

    Medical - Diagnostics & Research


  • Website

    https://www.radnet.com


  • Sector

    Healthcare


Fundamentals

Shape

264.86x

P/E Ratio

2.94x

P/S Ratio

4.52x

P/B Ratio

1.9

Debt/Equity

1.6%

Net Margin

$-0.4

EPS

How RDNT compares to sector?

P/E Ratio

Relative Strength

Shape

RDNT

Sector

loading...

Top 5 RS in Group

Symbol

Company

RS

5-Day Perf.

Forecast

Shape

$2B

Shape351%

2026-Revenue

$0.69

Shape235%

2026-EPS

$390M

Shape1891%

2026-EBITDA

Analyst rating

Strong Sell

Sell

Buy

Neutral

Strong Buy

Shape

Buy

Price Target

0.00(-100.00%)

Number of analyst

0

Last analyst upgrade/downgrade

Raymond James

upgrade

Previous: Outperform

2025-03-05

Now: Strong Buy

Barclays

upgrade

Previous: Equal-Weight

2024-09-06

Now: Overweight

B. Riley

initialise

Previous: Not converted

2023-03-31

Now: Buy

CJS Securities

initialise

Previous: Not converted

2023-03-31

Now: Outperform

Earnings GrowthShape

status-upYoY

Current

Estimates

Q2.23

arrow
arrow

+60%

0.24
vs 0.15

Q3.23

arrow
arrow

+56%

0.14
vs 0.09

Q4.23

arrow
arrow

+82%

0.2
vs 0.11

Q1.24

arrow
arrow

+188%

0.07
vs -0.08

Q2.24

arrow
arrow

-33%

0.16
vs 0.24

Q3.24

arrow
arrow

+29%

0.18
vs 0.14

Q4.24

arrow
arrow

+10%

0.22
vs 0.2

Q1.25

arrow
arrow

N/A

-0.35
vs 0.07

Q2.25

arrow
arrow

-22%

0.12
vs 0.16

Q3.25

arrow
arrow

-6%

0.17
vs 0.18

Sales GrowthShape

status-upYoY

Current

Estimates

Q2.23

arrow
arrow

+14%

403.7M  vs 354.4M

Q3.23

arrow
arrow

+15%

402M  vs 350M

Q4.23

arrow
arrow

+10%

420.4M  vs 383.9M

Q1.24

arrow
arrow

+11%

431.7M  vs 390.6M

Q2.24

arrow
arrow

+14%

459.7M  vs 403.7M

Q3.24

arrow
arrow

+15%

461.1M  vs 402M

Q4.24

arrow
arrow

+13%

477.1M  vs 420.4M

Q1.25

arrow
arrow

+9%

471.4M  vs 431.7M

Q2.25

arrow
arrow

+6%

489M  vs 459.7M

Q3.25

arrow
arrow

+7%

493.5M  vs 461.1M

Return on EquityShape

status-upQoQ

Q2.23

arrow
arrow

+1%

0.01
vs -0.04

Q3.23

arrow
arrow

+3%

0.03
vs 0.01

Q4.23

arrow
arrow

0%

-0.00
vs 0.03

Q1.24

arrow
arrow

0%

-0.00
vs -0.00

Q2.24

arrow
arrow

0%

-0.00
vs -0.00

Q3.24

arrow
arrow

+2%

0.02
vs -0.00

Q4.24

arrow
arrow

+1%

0.01
vs 0.02

Q1.25

arrow
arrow

NA

NA
vs 0.01

Institutionnal OwnershipShape

status-upQoQ

Q2.23

arrow
arrow

194

194
vs 156

24%

Q3.23

arrow
arrow

199

199
vs 194

3%

Q4.23

arrow
arrow

225

225
vs 199

13%

Q1.24

arrow
arrow

283

283
vs 225

26%

Q2.24

arrow
arrow

287

287
vs 283

1%

Q3.24

arrow
arrow

310

310
vs 287

8%

Q4.24

arrow
arrow

339

339
vs 310

9%

Q1.25

arrow
arrow

318

318
vs 339

-6%

Earnings Growth

Latest News